hrh PrinCess haYa to hiGhliGht develoPMents in

Transcription

Can You Guess
the Most Common
Medical Procedure?
Pediatric International Program
• Neuroblastoma Program
• Level 4 Epilepsy Center
• MIBG Suite
• Movement Disorder Program
RENAISSANCE IN
HEALTHCARE
P8
cookchildrensinternational.org
01-682-885-3260
P10
• Level 4 Epilepsy Center
• Neuroblastoma Program
• Movement Disorder Program
• MIBG Suite
01-682-885-3260
cookchildrensinternational.org
DAY 01
MONDAY
25 JANUARY 2016
WELCOME TO
ARAB HEALTH 2016
HRH Princess Haya to highlight
developments in genomics and
personalised medicine
Leaders in Healthcare Conference will highlight benefits of
personalised
medicine
to overcome
limitations of Is
traditional
medicine
Where
The
Future
Of Healthcare
On Display
T
strong focus on 3D medical printing, a field that
represents a new frontier in medical technology.
Arab Health 2016 introduces the 3D Printing
Zone, an area where visitors can watch and learn
from the companies pioneering this new field
through a variety of hands-on activities, interactive
demonstrations and face-to-face conversations. The
3D printing Zone can be found in Hall 5.
This focus on 3D medical printing extends
to the brand new 3D printing conference track
taking place on the 26th and 27th of January. The
conference will examine the surgical applications
for 3D printing, 3D printing for drug discovery,
bioprinting and vascularization as well as a look
at the legal and ethical debates surrounding this
emerging technology.
Vice-President
the CME
UAE
This year’s and
ArabPrime
healthMinister
featuresof 20
and Ruler conference
of Dubai, the
Leaders
accredited
tracks
across intheHealthcare
four days
Conference
will highlight
developments
in the
of
the show. The
Congress,key
accredited
by Cleveland
areas of
human
Clinic
hasDNA,
grownmolecular
every yearand
with
2016 genomics,
adding a
as well ofasnew
challenges
opportunities and
in
number
tracks suchand
as rheumatology
personalised
to improve
image
guided health
intervention
amongpatient
others.treatment
outcomes
in the
region.
Alongside
theArab
ever-growing
conferences and
Attendees
exhibition
spaceatatthe
Arabconference
Health, thewill
15thinclude
edition Dr
of
Amer Sharif,
Managing
Director,
Dubai
MEDLAB,
running
alongside
the event
hasHealthcare
moved to
Drlocation,
Azad Moopen,
Chairman
andHalls
Managing
aCity,
bigger
now occupying
Za’abeel
4-7 at
Director, Aster DM Healthcare, among other
dignitaries.
Commenting on the benefits of personalised
healthcare Dr. Keith Stewart, director for the Mayo
Clinic Center for Individualized Medicine said, “By
tailoring each patient’s diagnosis and treatment,
we optimise care and transform how our patients
receive treatment. Precision medicine has the
potential to effectively and accurately diagnose,
treat, predict and eventually prevent disease.”
“The Leaders in Healthcare Conference is a
distinguished platform which gathers thought leaders
and industry experts to share and discuss new
trends, and exciting opportunities and advancements
in the field of healthcare. Siemens Healthcare is
proud to be a partner of this prestigious conference,”
he Arab Health Exhibition and Congress,
now in its 41st year has long been a staple
in the region’s healthcare calendar. When it
first began, it was an opportunity for exhibitors to
introduce their products to a market that was in its
infancy. As the healthcare landscape in the region has
grown, so too has Arab Health, cementing itself at the
heart of what is now a booming healthcare market.
The Middle East now offers world-class
healthcare that rivals the high standards set in other
parts of the world. The GCC in particular is no
longer playing catch up to older, more established
markets as it pushes ahead with the deployment
of new technologies and innovative healthcare
solutions. This year’s Arab Heath is no different, as
the largest event of its kind in the region it brings
together over 4,000 companies and more than
130,000 visitors from 163 countries.
Arab Health has, according to Simon Page
the Managing Director of Informa Life Sciences
Exhibitions “the unique ability to bring together
the world under one roof and exhibit the latest
products, technologies, services and networking
opportunities for the healthcare industry.”
In addition to its grand scale, the show has
set its sights on the future of healthcare with its
M
arking the final day of Arab Health
Exhibition & Congress 2016, the Leaders
in Healthcare Conference, one of the
most prestigious, high-level healthcare conferences
in the Middle East, will open today and focus on
the latest developments in personalised medicine
and genomics. Held under the patronage of the
Chairperson of Dubai Healthcare City Authority
(DHCA), HRH Princess Haya Bint Al Hussein, wife
of HH Sheikh Mohammed Bin Rashid Al Maktoum,
the Dubai International Convention & Exhibition
Centre. An additional 100 companies will join the
exhibition to promote and launch the latest diagnostic
innovations and services. New conference rooms will
accommodate the growing delegate numbers, making
the MEDLAB Congress the largest in the world.
In order to allow you to get the most out of
your visit to Arab Health this year, don’t forget to
download the Arab Health mobile app from the
website: http://arabhealthonline.com/mobileapp/
The app will help you navigate the expansive
floor plans, browse through the thousands of
exhibitors and products, and personalise your
experience by creating your own favourites and
notes, all from your own device.
Finally, as a further help to visitors and as a first
saidevents
Dr. Bernd
President
of the
Region
for
in theOhnesorge,
region, Arab
Health has
partnered
Centralmyconcierge.com
and Eastern Europe,
Middlehas
Eastcreated
and Africaa
with
which
at SiemensforHealthcare.
“Withdiscover
today’s
microsite
attendees He
to added,
help them
changing
challenges,
Siemens
dining
and environment
entertainmentand
options
during the
show,
Healthcare
aims toandenable
healthcare
providers
as
well as activities
attractions
to enjoy
before,
worldwide
in delivering
improved clinical outcomes
during
and after
Arab Health.
withArab
increased
operational
efficiency
lower
”
Health
2016 looks
set toatbe
thecosts.
most
The edition
2016 Leaders
exciting
yet andinweHealthcare
wish you aConference
successful
will feature
contributions
and
productive
four days. by Lord Stephen Carter,
GroupWhite,
CEO Editor,
Informa,Arab
organiser
Arab Health;
Nick
HealthofMagazine
Dr Keith Stewart, Director of the Center for
Individualized Medicine, Mayo Clinic; Pamela D Paulk,
President, John Hopkins Medicine International;
Homer Pien, Chief Technology Officer, Imaging
Systems, Philips Healthcare; and other healthcare
leaders from across the globe.
Healthcare stakeholders in the Middle East can
now leverage the increased power of genomics
and growth of personalised medicine to be better
equipped to prevent, diagnose, treat and predict
outcomes based on complex information, including
genetic data.The Leaders in Healthcare Conference
will address developments in personalised health,
and applications for some of the Middle East’s most
pressing health issues such as diabetes, inherited
diseases and cancer.
MightySat
Pulse Oximeter
The FutureFingertip
of Information
Featuring
Masimo
SET (Signal Extraction Technology )
Display
& Interaction
TM
®
®
Please visit Masimo at Saeed Hall 1, Stand S1B30 and be among the first owners of MightySat™ Rx
Please come to Masimo’s Booth at Saeed Hall, Stand S1B30 and Experience First Hand
Fingertip Pulse Oximeter. Limited offer*, order your new MightySat™ Rx now at a 50% discount.
our Live Demo: a Prototype Display & Touch-free Interactions. Provide your Feedback on
Features, Usability and Requirements.
*Limited offer, only one device per registered attendee
© 2016 Masimo. All rights reserved.
PLEASE VISIT MASIMO
Apple is a registered trademark of Apple Inc. registered in the U.S. and other countries.
Bluetooth is a registered trademark owned by Bluetooth SIG, Inc.
Saeed Hall
Stand S1HB30
SM
www.masimo.co.uk
www.masimo.co.uk
**The Masimo Professional Health app is downloadable from the App store for iOS devices or
Google Play™ store for select Android devices. For an up-to-date list of compatible smart devices,
see: www.masimoprofessionalhealth.co.uk. Only available for Bluetooth® LE enabled models.
Daily
267mm.indd
Daily Dose
Dose final
day 263mm
and 3xair
glass 63mm1x 267 mm .indd 1
Free Downloadable Masimo
Professional Health App**
> View, trend, and share up
to 12 hours of data
iPhone not included
18/01/16 14:52
14:28
18/01/16
ARAB HEALTH daily dose
How Preventative Medicine Can Provide
New Opportunities in the Gulf Region
P
reventative medicine has the ability to
transform the healthcare landscape in
the GCC in addition to providing new
opportunities and revenue streams for healthcare
providers. With falling oil prices and people across
the region feeling a tightening of the purse strings,
it is time for the healthcare industry, both providers
and insurers, to act now.
The gulf region has enjoyed rapid economic
development over the last 30 years. As a result,
the kinds of healthcare challenges the region faces
have changed dramatically. Where communicable
disease and malnutrition were once the major
hurdles to be overcome, the Gulf States must
now contend with lifestyle conditions such as
obesity, heart disease and diabetes. Indeed, as
much as 20% of the UAE population suffer from
diabetes, placing the country at 16th place in the
global ranking for highest rates of the disease. In
addition, according to the Health Authority Abu
Dhabi, “cardiovascular disease accounted for
36.7% of all deaths in 2013”. According to Dr
Nooshin Bazargani of the Dubai Health Authority
the average age of people suffering from heart
attacks in Dubai was recently revealed to be just
49, due, in large part, to diabetes, tobacco use and
hypertension.
The impact of chronic illnesses on society will
without a doubt increase as the region undergoes
demographic change. A falling birth rate and higher
life expectancies will contribute to a significant
rise in the elderly population. Indeed, a survey by
McKinsey & Company estimated that the number
of people over 65 would increase by 25% over
the next 25 years. The long term care needs of
patients in the GCC will fall to government and
private healthcare providers.
Healthcare costs in the region are already
seen as becoming problematic. Indeed, the Dubai
Health Authority recently moved to control prices
in the emirate by requiring providers to request
2
approval before they increase them further.
The rising cost and increased demand for
healthcare both have the potential to hurt the
regions’ competitiveness on the world stage. This
is especially true in the UAE where employers are
now required to provide health insurance to their
employees, increasing the cost of doing business in
the Emirates dramatically.
All this comes at a bad time for the oil rich
region as tumbling oil prices are set to put the
squeeze on both public and private purses. The
stage then, is set for a showdown between those
paying for healthcare and those providing it. If left
unchecked, the rise in chronic diseases alongside
an ageing population and tighter budgets could
prove to be a burden the region simply cannot
continue to carry.
There is, however, an opportunity in what some
might see as a ticking time bomb. Preventative
medicine -if fully embraced by healthcare providers
and, crucially, those that pay the bills – could stop
the increase in chronic diseases in its tracks and, in
the long term, reduce their overall incidence.
While it is seen as expensive, effective practice
of preventative medicine can reduce long-term
health expenditure by keeping people informed of
their risk factors and providing them with methods
to change their lifestyle or mitigate that risk. Indeed,
heart disease and diabetes are strongly linked to
lifestyle choices such as diet and smoking.
Preventative medicine and patient outreach, if
approached correctly, can reduce healthcare costs
and expenditure as well as ease the burden on
healthcare providers. In addition to a predicted
shortage of bed space in the UAE, healthcare
providers across the GCC find it hard to source
medical talent due to a lack of local educational
institutions. For example, there is a shortage of
oncology specialists in Abu Dhabi.
Further, preventative medicine presents a
variety of opportunities for cooperation between
facebook.com/arabhealth
the public and private sectors as well as between
healthcare providers and insurance companies.
Governments in the region are well aware
of the challenges posed by their changing
demographics and the rise of lifestyle related
chronic illnesses. Indeed, most have unveiled plans
to combat the rise through public awareness
campaigns on subjects such as breast cancer
and the dangers of smoking. However, there
is a feeling in the private sector that they need
to better support such initiatives as they tend
towards the more reactionary side of healthcare.
Medcare Hospital CEO Dr Ala Atari recently
called for the private sector to do more than just
the activities they organise around events such as
breast cancer awareness day citing public-private
partnerships as a key measure to ensure regular
screenings for a variety of chronic diseases such
as cancer and diabetes. Indeed, early detection of
such conditions is key to their successful treatment
and management. The importance of dealing
with chronic illnesses has been taken onboard by
government with the Health Authority Abu Dhabi
citing it as a key pillar of its healthcare strategy for
the coming five years.
The role of the insurance industry in
preventative medicine cannot be overlooked.
Partnerships between healthcare providers and
insurance companies can be excellent drivers
of revenue for the providers and a great way to
control expenditures for the insurance company.
Strides are already being made in the field with
AXA Gulf teaming up with Al Zahra Hospital to
set a new world record in cholesterol screening.
Their joint campaign attracted 2420 participants
in eight hours at a recent event in Dubai. Longerterm cooperation however, can only have positive
outcomes for all parties involved be it insurers,
providers and, crucially, patients. There are already
examples of such cooperation such as that
between Al Noor Hospital and Green Crescent
Insurance in 2010. The partnership resulted in a
specialised diabetes clinic aimed at helping patients
better understand their condition and how best
to manage it themselves in order to minimise
the requirement for medical intervention. Green
Crescent CEO Carl J. Sardegna highlighted the
benefit of the move by stating, “the average cost
for treating an employee with diabetes is 13 times
greater than the health care expenses associated
with a ‘healthy’ employee.”
In an economic landscape where employers
in the region may soon be tightening their belts,
initiatives such as these should come as a breath
of fresh air. If lasting and effective partnerships
can be forged between healthcare providers and
other actors in the public and private sectors, they
will surely have a positive impact on the region
as a whole. Lower healthcare costs will boost
the region’s competitiveness on the international
stage, healthier residents will contribute more to
the economy and, crucially, new revenue streams
will be opened for healthcare providers who
will, in addition, find the burden on their facilities
reduced. Indeed, Al Noor Hospitals announced a
79% increase in profits for the first half of 2014
due in large part to a rise in treatment of patients
who didn’t require an overnight stay in hospital.
A clear, long term strategy for patient
outreach, monitoring and preventative medicine
has clear benefits for those who bring them to
market, especially given the possible partnership
opportunities of such ventures. While one day
special events centred around diabetes, breast
cancer or other illnesses are a first step, longer and
deeper commitments might well leave healthcare
providers with higher margins, health insurers
paying out less in treatment costs and companies
saving money on their insurance premiums. All
players in the region’s healthcare market should
therefore view preventative medicine as an
opportunity.
THURSDAY 29 January 2015
Today at a glance
Arab Health 2016 Congress
Conference
ROOM
Location
Leaders in Healthcare
Al Multaqua Ballroom
Clinical Chemistry - (Medlab)
Arab Health Daily Dose
The Arab Health Daily Dose is the official newspaper of the Arab
Health Exhibition & Congress. Distributed Monday 25 JanuaryThursday 28 January 2016.
Publications Director Joseph Chackola
[email protected]
Start Time
Finish
Between Halls 4 & 5
1000
1400
Zabeel 6 Room 1
New Hall Zabeel 7
920
1630
Assistant Editor Deepa Narwani
[email protected]
Haematology (Medlab)
Zabeel 6 Room 2
New Hall Zabeel 7
1000
1630
Sales Manager – Print & Online Waseem Ashraf
[email protected]
Quality Management
Shk Rashid Hall - Part C
Shk Rashid Hall
930
1730
Total Radiology
Shk Rashid Hall - Part D
Shk Rashid Hall
900
1630
Gastroenterology
Dubai C&D
Above Shk Maktoum Hall
850
1730
Senior Graphic Designer Mark Walls
[email protected]
Image Guided Interventions
Abu Dhabi A
Above Shk Maktoum Hall
900
1810
Group Marketing Director Celine Fenet
[email protected]
Public Health
Abu Dhabi B
1st Floor building opp Hall 5
900
1645
Cardiovascular
Ras Al Khaimah
2nd Floor building opp Hall 5
850
1630
Surgery
Umm Al Qwain
2nd Floor building opp Hall 5
850
1730
Hypertension
Al Ain J&K
Above Hall 4
800
1800
Editor Nicolas White
[email protected]
Advertising Sales Executive Hina Khan
[email protected]
Marketing Manager Hannah O’Toole
[email protected]
The Arab Health Daily Dose is owned and distributed by Informa Exhibition Life Sciences,
Floor 19, World Trade Centre Tower, Dubai, UAE.
All images © Shutterstock.com unless otherwise specified.
This publication may not be reproduced or transmitted in any form in whole or part
without the written consent of the owners.
For more information on Informa Exhibitions Life Sciences publications, please visit www.
arabhealthmagazine.com
because you demand the best, we arrange it
Experience only the best of
Dubai during Arab Health 2016
with your concierge
Book now at myco.ae/ah
Gourmet Indian business lunch
at Junoon, Shangri-La Dubai
AED 126
See the best of Dubai on a
helicopter tour of the city
Share a Middle Eastern
tasting menu at Qbara
AED 895
Indulge in a 2-hour spa session
at Sofitel Dubai Downtown
AED 450
AED 665
3D PRINTING ZONE AT ARAB HEALTH
Visit Hall 5 to experience first-hand the technology that is set to revolutionise healthcare
Hosting leading global research groups and pioneering technology companies showcasing their cutting-edge products, this feature area is
bringing innovation to a brand new audience.
The 3D printing zone is a unique open space which has been devised as a dedicated educational experience for all those who are interested in
learning about the latest 3D technologies entering the MENA market for the first time.
Visit the zone to observe and learn from the pioneers in the field of 3D bioprinting with:
¢ hands-on activities
¢ interactive demonstrations
¢ face-to-face conversations with those who bring these technologies to life
The 3D printing zone will bring together the companies that are at the forefront of developing, and successfully commercialising, this
groundbreaking technology.
Watch Arab Health TV
at www.arabhealthonline.com
#arabhealth
@arab_health
3
Leading the way
L
eader Healthcare does it again! Underlining
their massive influence on the healthcare
segment in the Middle Eastern market
since 2009, their robust participation with an
impressive presence at the Arab Health 2016, just
goes to prove their dominance and leadership in
providing state-of-the-art innovative products to
the medical fraternity.
Today they represent a plethora of brands
and principles covering a wide range of segments
within the healthcare sector.The fact that Leader
Healthcare represents close to 50 International
brands across the entire GCC is a testament
to their unquenchable thirst for technological
innovations which save lives, improve the quality
of care-giving and strengthen the hands of the
healthcare professionals.
This quest to be the leader in their field
of expertise has seen them branch out to
ever expanding horizons and the company
is present in the UAE, Saudi Arabia, Qatar,
Oman, Kuwait, Bahrain and India.
Leader Healthcare has always appreciated
the partnerships it has forged over the years
with various partners and stake holders. One
such association is with the Arab Health
Exhibition. Beginning with a discreet presence,
today the size and the magnitude of their
presence has grown tremendously.
Vision, Planning and Integrity is the core of
what they believe and deliver, and they cater
to the needs of different healthcare providers
such as emergency medical services, education,
hospitals, nursing, civil defense and the military.
In addition, Leader Healthcare has also
grown to be the leading Turnkey Projects
Solutions provider for Training Centre’s,
Hospitals and Poly Clinics. With eyes firmly
set on being the most versatile healthcare
provider for not only the GCC, but the entire
world, plans are afoot in breaking new ground
into the Northern American market.
SolSteo’s industrial ethylene oxide
(EO) sterilizers come with a 10-year
guarantee at Arab Health 2016
S
olSteo guarantees its sterilizationchambers
for 10 years. This guarantee is given in full
confidence because their design has been
independently validated by the TÜV. Manufacturing
EO industrial sterilizers is complex: it requires
in-depth-understanding of the sterilization
process and safety standards governing their use
(European ATEX Directives, FDA 21, CFR Part 11,
ISO 11135, etc.). This explains why only a handful
of manufacturers prove reliable. Determined to
succeed on the international scene, SOLSTEO
is the only French manufacturer exporting the
product (95% of its sales revenue).
Over the years, repeated constraints
due to vacuum and pressure cycles in the
sterilizationchambers cause significant material
fatigue and risk of leakage. In order to guarantee
optimal manufacturing quality, Solsteo conducted
specific studies on fatigue with the TÜV. Purchasing
an EO sterilizer is a long-term industrialinvestment
that needs to last.
The automation system is also reliable thanks
to the programs developed by CristalDoc,
theEuropean leader in control and monitoring
software for EO sterilizers. Not only are SolSteo
and CristalDoc activities complementary, but they
are also managed by the same persons and have
the same shareholders. The result is a robust,well
organized and reactive organization capable to
centralize knowledge on the EO sterilization
processes and to manage a team of experts,
ensuring competitiveness and quick execution time,
ongoing quality control.
Two major breakthroughs in automation have
come of this:
EQ-Sim: A simulation tool to test programs
prior to installation, by reproducing the physical
parameters of the sterilizer in real operation.
Consequently, programs are 95% validated “offsite”, from SolSteo’s Paris based offices. “On-site”
installation and validation then take a few days only.
Embedded memory: A buffer memory,
located directly into the Programmable Logic
Controller to offset the communication failures
intrinsic to IT systems. This software feature makes
it possible to fully guarantee the recording and the
printing of all cycle data in the final report.
SolSteo can provide EO sterilizers on a standalone basis, or as complete turnkey projects, including
pre-conditioning and aeration rooms, automatic
loading/unloading solutions and gas treatment
systems (scrubbers and catalytic burners). It also
offers remote technical assistance services, spare
parts, maintenance/calibration services, consulting
and ATEX training (INERIS-certified ISM-ATEX).
SolSteo serves customers across the world,
with strong business in the Middle East: Saudi
Arabia, Qatar and the United Arab Emirates. The
company specializes in integrating EO sterilizers into
manufacturing processes (“in-house” sterilization). It
has several projects underway for new plants or
for revamping of existing sterilizers in the region.
Present every year at Arab Health, it takes the
opportunity to know-how and expertise in EO
sterilization processes, unveil its latest innovations
and share industrial best practices with local players.
Za’abeel Hall 2 – Booth Z2G70
Visit us at
MEDLAB
Booth #Z4E40
Test smarter. Run faster.
Siemens answers unite clinical and workflow excellence to help you thrive.
www.siemens.com/ArabHealth
Clinical diagnostic testing is part science and part business. Which means its overall
performance depends on how well these two integral parts work together. Siemens Healthcare
Diagnostics can make that happen. We offer answers that combine the extensive menu of tests
you want with the leading-edge technology you need to run them efficiently. Not only do we
deliver assays to support your clinical excellence, we commit all our technical know-how to
developing innovative diagnostic solutions that increase productivity. What’s more, we provide
4
the education, services, and support that keep you running at your absolute best. So you can unite
and transform both clinical and workflow performance to deliver the highest-quality patient care.
Find out how Siemens helps you work better by working with you.
Visit siemens.com/test-smarter.
Disaster Drill Helps Hospitals
Prepare for Emergencies
Johns Hopkins experts provide real-time insights on
best practices when dealing with catastrophic events
Y
inventory of resources and the operating room’s
capacity, among other critical areas.
“These disaster drills are not meant to test
individuals. They provide a no-fault learning
environment to test and improve emergency
procedures,” says Catlett, who has responded to
emergencies around the world.
After the drills, a formal assessment, including
feedback from participants and evaluators with
concrete recommendations, is presented to hospital
leadership.
The disaster drill at Al Rahba Hospital is the
latest in a series of projects tied to its affiliation with
Johns Hopkins Medicine International, the global
arm of Johns Hopkins Medicine, which seeks to
improve the health of the community and the world
by setting the standard of excellence in medical
education, research and clinical care.
“Because of our years of affiliation with hospitals
in the Middle East, like Al Rahba Hospital, we are
able to shape our services to meet the specific
needs of the region,” says Sharaf Saleh, Middle East
Director for Johns Hopkins Medicine International.
“We understand the cultural sensitivities of our
affiliates and work together with our colleagues
in the region to provide meaningful programs to
advance high standards of patient care.”
Some noteworthy “firsts” from the collaboration
between Johns Hopkins Medicine International and
its affiliates in the Middle East include the first official
two-way residency programme exchange between
The Johns Hopkins Hospital and the UAE, the first
mobile mammography screening and awareness
programme in the UAE, and the first formal
collaboration designed to advance eye care and
eye research with the largest eye hospital in Saudi
Arabia.
“We are proud to report that in the last decade,
we have guided our Middle East affiliates to achieve
12 Joint Commission International accreditations
and reaccreditations,” says Saleh. “We also share
with our affiliates the latest research advances
and practices achieved by Johns Hopkins faculty
members in Baltimore so they can be quickly applied
at the bedside. That gives the local population the
option to access the best care closer to home.”
TP 49 2.0 02/2015/A-LB
ou have a plan, a protocol and a
communication tree. But is your hospital
really ready to respond to an emergency?
The Johns Hopkins Office of Critical Event
Preparedness and Response (CEPAR) helps
institutions around the world answer that question.
“When an emergency hits, we often see how
plans that looked good on paper and had been
reviewed begin to fail,” says Christina Catlett,
Associate Director of CEPAR. “We create and
implement tailored disaster drills so hospitals can
test the systems they have in place and evaluate
their effectiveness.”
Catlett, an emergency medicine physician with
20 years of experience at The Johns Hopkins
Hospital in Baltimore, Maryland, USA, recently led
a disaster drill at Al Rahba Hospital in Abu Dhabi,
UAE.
Hospital employees reacted to a planned
scenario of a multivehicle motor crash that brought
in 60 volunteers playing the roles of patient and
family members. Before the drill, “patients” received
a specific medical scenario and went through a
moulage session to get makeup wounds resembling
the condition they were playing.
Physicians and nurses from Al Rahba Hospital’s
Emergency Department activated their crisis plan
to respond to a drill that lasted about three hours.
The exercise looked at the hospital’s mass casualty
incident notification system, triage assessment,
IMAGE1 SPIES™ – Your Link to Perfection
Innovative Visualization Options for Surgical
Interventions and Diagnosis in Endoscopy
KARL STORZ GmbH & Co. KG, Mittelstraße 8, 78532 Tuttlingen/Germany
KARL STORZ Endoskope–East Mediterranean and Gulf S.A.L, Block M, 3rd Floor, Beirut Souks, Weygand Street, 2012 3301 Beirut/Lebanon
www.karlstorz.com
#arabhealth
@arab_health
5
Perioperative Enhanced Recovery Programme that Included
Masimo PVI Reduced Length of Stay, Complications and Costs
M
asimo’s non-invasive PVI is a measure
of the dynamic changes in the
perfusion index that occur during one
or more complete respiratory cycles.
In the retrospective study of the Enhanced
Recovery programme implemented at the
University of Virginia (UVA), Dr. Rober t
Thiele and colleagues compared the results
of 109 patients managed with the programme
to 98 consecutive patients before the
programme was implemented. The Enhanced
Recovery programme included ingestion
of a carbohydrate drink two hours prior to
surgery, pre-operative multimodal analgesic
regimen, goal-directed therapy with Masimo’s
PVI, intraoperative low-dose spinal morphine,
limiting intraoperative opiates, intraoperative
infusions of ketamine and lidocaine (continued
48 hours post-operatively), early mobilisation,
and oral intake post-operatively.
Researchers observed that, as compared
to the standard of care group, patients in the
Enhanced Recovery program had:
2.3 fewer days of hospitalization (4.6 ± 3.6 vs
6.8 ± 4.7, p = 0.0002)
Reduced mean direct cost ($13,306 vs
$20,435, equating to savings of $777,061, p <
0.001)
Fewer surgical site infections (7.3% vs 20.4%,
p = 0.008)
Less fluid administered (848 mL vs 2,733 mL,
p < 0.0001)
Lower total hospital morphine equivalents
(63.7 mg vs 281 mg, p < 0.0001)
Considerable improvements in patient
satisfaction scores
6
Overall satisfaction increased to the 59th
percentile, from 26th
“Felt ready for discharge” increased to the
99th percentile, from 41st
Satisfaction with pain control increased to
the 98th percentile, from 43rd
Likelihood that patients would recommend
the hospital increased to the 89th percentile,
from 32nd
Researchers stated: “The 2.3-day reduction in
LOS for the 109 patients on the ER protocol
equated to a savings of 261 patient-bed days.
Given that the UVA institutional average LOS
is 5.5 days, this allowed the Medical Center to
admit 47.5 additional patients during this time
period as the direct result of the protocol.”
The study concluded: “Implementation of an
ER protocol led to improved patient satisfaction
and significant reduction in LOS, complication
rates, and cost for patients undergoing both
open and laparoscopic colorectal surgery. These
data demonstrate that small investments in the
perioperative environment can lead to large
returns.”
Recruitment Solutions
www.healthrecruitment-informa.com
LOOKING FOR A
CAREER CHANGE?
ONLINE JOB PORTAL
www.healthychange.jobs
The only job portal dedicated to the recruitment process of medical professionals for careers
in the Middle East and Abroad.
Ÿ Search through hundreds of medical jobs
Ÿ Apply online for free
Ÿ Personalise your profile to allow employers to
Ÿ Stay up to date with the healthcare
find you
industry worldwide
LIVE EXHIBITIONS
www.healthrecruitmentfair.com
An international platform for healthcare recruitment and career development.
London,
UK
15-17 September 2016
130 Exhibitors
4,000 Visitors
10 Free conferences
400 Job vacancies
Abu Dhabi, 22-24 October 2016
UAE
100 Exhibitors
8,000 Visitors
14 Free conferences
500 Job vacancies
Visit us in the Recruitment Zone
Stand CB25
Can You Guess the Most
Common Medical Procedure?
Hint: it’s something you started doing as an infant
Quick, name the most
common medical
procedure.
Chances are, you didn’t guess “communication,”
but physicians are said to have more than 200,000
patient interactions over a lifetime. Each one is
an opportunity to share information, motivate
behaviors, and build a relationship.
Cleveland Clinic has found that physician
communication focused on building an authentic
relationship with the patient has profound
therapeutic
benefits. Relationship-centered
communication not only produces better
outcomes and a better patient experience; it can
be a protective against career burnout.
Not listening has a
cost
Still, communication is rarely taught in medical
school. Most physicians develop communication
strategies through trial and error, but close study
of physician-patient interactions shows that many
effective communication skills are counterintuitive.
Consider, for instance, the importance of
listening. Research shows that physicians will ask
a patient a question, and then interrupt patients’
answer after only 18 to 23 seconds. The result is
that patients don’t get to tell their story; they may
never utter their main concern.
Physicians who don’t listen may fail to diagnose
— or may misdiagnose — patient problems, and
then wonder why.
Physicians should begin their patient encounter
with an open-ended question. They need to keep
asking, “What else?” until all patient concerns are
addressed.
Some physicians fear that if patients are
allowed to talk, they will go on and on forever.
Yet, according to one study, patients who are not
interrupted usually complete what they have to
say in about 90 seconds. Another study shows
the average outpatient has 1.7 concerns — and
the main concern is rarely the first mentioned.
Offering open-ended inquiries and allowing
patients to talk makes it less likely that patients
will introduce their main concern as a “doorknob
question.”
Empathy and the REDE
Model
Empathy is another critical part of communication.
Most physicians feel empathy for their patients,
but fewer know how to demonstrate it. Empathy
can be communicated by words or gestures. I’ve
written before about how my experience running
a wartime military hospital taught me the value of
simple touch to communicate reassurance.
Verbally, we must let patients know we
support them and appreciate the difficulty of
what they’re going through. They should know
that their feelings are valid and that we sense
their emotions.
Over the past six years, Cleveland Clinic’s
Office of Patient Experience has focused intently
on these issues. They developed and refined a
model for relationship-centered communication
they call the REDE Model. REDE stands for
Relationship:
Establishment;
Development;
Engagement. Very broadly, it gives providers
an adaptable toolkit of habits, behaviors and
strategies to establish, develop and engage
patients in a therapeutic relationship. It reduces
the asymmetry of the physician-patient encounter,
and makes both parties collaborators.
We have trained more than 4,000 Cleveland
Clinic staff doctors and almost 400 advanced
care providers in these special skills since 2011.
8
Since that time, our HCAHPS scores for Doctor
Communication have improved 40 percentile
points. Studies show that physicians who master
relationship-centered communication gain selfconfidence, become better diagnosticians and
take more satisfaction in their work. The result
is less burnout, fewer malpractice claims, and less
expensive care.
Interpersonal skills
are key
In May, more than 2,000 people from around
the world came to Cleveland for the 2015
Empathy+Innovation
Patient
Experience
Summit, presented by Cleveland Clinic’s Office
of Patient Experience. The theme was “Empathy
Amplified,” and the emphasis was on all aspects
of communication in the healthcare setting.
Patients today have more healthcare choices
than ever. Many value their providers’ interpersonal
skills at least as much as their medical judgment. If
you lack these skills, you’re likely to lose patients.
We need better communications skills to survive
and thrive. It’s the smart thing to do and the right
thing to do for our patients.
Help for GI Tract
Diseases
POEM, ESD among new group’s minimally
invasive offerings
Today, many GI tract diseases that once
required surgery can now be treated
without incisions. At Cleveland Clinic, a new
Developmental Endoscopy Group can help your
patients with conditions ranging from motility
disorders — such as achalasia — to esophageal,
gastric and colorectal cancer.
“This new effort combines laparoscopy and
endoscopy, which have traditionally been separate
groups,” explains Matthew D. Kroh, MD, Director
of Surgical Endoscopy in Cleveland Clinic’s
Digestive Disease Institute. “Now we have a core
group of interventional endoscopists who are
embarking on these procedures — functionally
operating through the endoscope.”
The Developmental Endoscopy Group, a
fusion of gastroenterology, general surgery and
colorectal surgery experts, is headed by both Dr.
Kroh as Surgical Director and Mansour Parsi, MD,
MPH, as Medical Director.
The main focuses to date are peroral
endoscopic myotomy and endoscopic submucosal
dissection. Here is a closer look at each:
POEM FOR ACHALASIA
Peroral endoscopic myotomy (POEM) is an
entirely endoscopic procedure to treat achalasia.
The technique originated in Japan and has been
performed in the U.S. for approximately two years.
“Through the esophagus, we make a small
incision in the mucosa and make a tunnel
underneath it,” Dr. Kroh explains. “Then, we
cut the muscles in the esophagus — mainly at
the lower esophageal sphincter — which are
too tight in achalasia. It’s an effective way to
release this tension and restore the ability of
food to pass through the esophagus and into
the stomach.”
The Developmental Endoscopy Group
has successfully completed its first series of
POEM patients. Advantages include requiring
no incisions and patients returning home
the following day. Early data for POEM are
compelling, Dr. Kroh says. “It results in dramatic
relief of achalasia symptoms — as good as a
surgical (Heller) myotomy, without the potential
morbidity associated with the incisions on the
abdominal wall,” he says.
Cleveland Clinic advanced endoscopist
Madhu Sanaka, MD, underwent POEM training in
Japan under Haroue Inoue, MD, who pioneered
the POEM procedure. Dr. Sanaka performs
POEM procedures along with Cleveland
Clinic thoracic surgeon Siva Raja, MD, who
specializes in esophageal surgeries. Dr. Sanaka
says, “Gastroenterologists and surgeons bring
different skill sets to the table, which translates
into the best possible care for the patient.”
ESD FOR GI CANCERS
Endoscopic submucosal dissection (ESD) allows
for the removal of early esophageal, gastric and
colorectal cancers through an endoscope while
avoiding more invasive surgery. This technique
was developed in Japan where early gastric
cancer is common.
At Cleveland Clinic, gastroenterologist Amit
Bhatt, MD, underwent intensive ESD training in
Japan thanks to grants from the American College
of Gastroenterology and the American Society of
Gastrointestinal Endoscopy.
Dr. Bhatt says ESD is valuable in the treatment
of early gastric and esophageal cancer. It allows
for a complete one-piece resection of cancers
allowing pathologists to verify curative resection
similar to a surgically removed tumor — an
opportunity that is missed with other endoscopic
ablation techniques.
The goal of ESD is to be curative. But, Dr.
Kroh adds, if it is not possible to remove the
cancer with negative margins and avoid an
operation, ESD gives the team a better idea of
how advanced the disease is prior to surgical
intervention: “For instance, when a surgeon and a
gastroenterologist do a gastric case together, the
beauty of it is that even if it doesn’t come out
endoscopically, the patient can still get the next
less invasive technique.”
Dr. Bhatt emphasizes that the collaboration
between gastroenterologists and general surgeons
is a remarkable benefit to patients who now have
another option to avoid a traditional intervention.
“Having an advanced endoscopist and a surgeon
work side by side allows us to combine our
expertise, ideas and innovations to develop novel
approaches to problems,” Dr. Bhatt explains.
Dr. Sanaka, who also performs ESD procedures
for neoplastic lesions in the GI tract, adds that
ESD is less invasive compared with surgery but
has similar outcomes.
The Developmental Endoscopy Group
has effectively used ESD for both gastric and
colorectal cancers over the past six months.
Different Tests for Different Breasts:
GE’s Automated Breast Ultrasound Examination adapts to individual
patient needs, doubling chance of detection (compared to mammo alone)
B
reast cancer is the most common
female cancer in the Middle East region,
representing 24% of all cancer cases
in Saudi Arabia according to a report by the
Kingdom’s National Cancer Registry. In the UAE
too, breast cancer is the third leading cause of
death and the most common among females,
according to reports by the Ministry of Health
and Dubai Health Authority.
Particularly affected are women with dense
breast tissue because of the difficultly it can
cause when trying to detect cancer early using
mammography. Having dense breast tissue
represents a significant risk factor because it
not only increases the likelihood of developing
breast cancer, but can also mask the appearance
of the disease on mammography scans.
At Arab Health 2016, the region’s premier
healthcare exhibition, GE Healthcare showcases
a new supplementary screening exam option;
Invenia™ Automated Breast Ultrasound System
(ABUS) - that can be used to increase cancer
detection sensitivity in dense breast tissue.
likelihood of finding invasive breast cancers
has a 55% relative increase when compared to
mammography alone.¹
A non-invasive examination, ABUS eliminates
operator variation with improved technique
standardization, and serves as a valuable tool in
the screening of women with dense breasts and
therapy- assessment.
Fast and effective
screening
Invenia™ ABUS is a powerful tool based on
ultrasound, which helps enable physicians to
detect cancer dense breast tissue and is designed
to support a fast and effective workflow.
The technology is a comfortable,non-ionizing and
non-invasive alternative to other complementary
options in screening for women with dense breast
tissue, allowing a volume acquisition of the entire
breast tissue within just 15 minutes.²
New innovative technologies such as highfrequency reverse Curve™ transducer or the
software-based ultrasound technology provide
the basis for excellent image quality.The Invenia™
ABUS review software displays 2D volume in a
patented, coronary 2mm layer management
from the skin surface to the chest wall. A recent
study found an analysis to be possible within
approximately three minutes³ and in contrast
to the hand-held ultrasound can result in time
savings for both clinicians and patients.
Technologies designed
for the individual
GE has been dedicated to mammography and
the fight against breast cancer for nearly 50
years. In 1966, GE had already introduced its
first mammography system, and in 1999 was at
the forefront of the transition from analogue to
digital technology.
2011 marked the introduction of
SenoBright™ - contrast-enhanced spectral
mammography in the European market. This
was followed two years later by GE’s digital
breast tomosynthesis, SenoClaire™, which is the
only FDA approved 3D breast tomosynthesis
that delivers the same dose as 2D view.
Visitors to Arab Health can gain an overview
of GE Healthcare’s advanced diagnostic solutions
that help in the region’s concerted efforts to
address the rising incidence of lifestyle diseases.
Visit GE Healthcare’s pavilion at Stand No: S3B10.
Increased sensitivity
in breast cancer
detection by up to 55%
Dense breast tissue makes it very difficult to
detect pathological lesions when they are still
very small which can lead to late diagnoses. Now,
a supplementary automated breast ultrasound
examination can increase the likelihood of
early breast cancer detection. Clinical studies
have shown that if the Invenia™ ABUS is used
in addition to a standard mammography the
#arabhealth
@arab_health
9
Clinical pain management is a
primary issue for clinicians and
other healthcare professionals
By Thomas Omogi
P
ain is a common occurrence, especially
for critically ill patients. According to
the American Cancer Society, an estimated
25 million Americans experience acute pain
due to injury or surgery each year. Over half of
medical and surgical ICU patients experience
significant pain, according to a study published
in Anesthesiology. In addition to experiencing pain
at rest that postoperative, chronically ill, or critically
ill patients experience, patients may experience
procedural pain or pain related to surgery, trauma,
burns, or cancer. Patients often experience pain
while being weaned from a ventilator. The Institute
of Medicine says that chronic pain affects 100
million Americans, more than heart disease,
diabetes, and cancer combined.
Acute or chronic pain severely diminishes
function and quality of life during the pain event
and, frequently, long afterwards. Pain can prevent
patients from participating in activities of daily
living, slow recovery, and can even prevent patients
from progressing through the treatment process,
such as weaning from mechanical ventilation.
Pain is the an “unpleasant sensory and
emotional experience associated with actual or
potential tissue damage, or described in terms
of such damage,” according to the widely used
definition issued by the International Association
for the Study of Pain(IASP) in 1979. This definition
emphasizes the complex and multi-dimensional
nature of pain.
The IASP also states that pain is always
subjective. It is important to remember that,
in addition to being a significant physiological
incident, pain is also highly personal and emotional.
Individuals learn about pain through traumatic
early life experiences, compounding the emotional
stress many patients experience when in pain. In
fact, most critically ill patients experience pain and
find it to be a significant source of stress.
Pain may be especially stressful with the patient
is unable to self-report pain, either verbally or
otherwise, because of altered level of consciousness,
the use of sedatives or neuromuscular blocking
agents or mechanical ventilation.The IASP reminds
practitioners that the “inability to communicate
verbally does not negate the possibility that an
individual is experiencing pain and is in need of
appropriate pain-relieving treatment.”The ability to
assess patient pain, even when the patient cannot
fully express his pain experience, is the foundation
for effective clinical pain management. Clinical pain management is associated with
improved patient outcome, especially in ICU
settings. Unrelieved pain, however, often has
deleterious effects. Pain is associated with acute
stress response, resulting in changes in vital signs,
neuro-endocrine function and psychological
distress including agitation.
Despite advances in analgesics, especially
opioids, pain remains largely under-evaluated and
under-treated, especially in some segments of the
population. Unrelieved pain can have significant and
long-lasting negative physiologic and psychological
consequences for patients. Many patients say that
pain is their greatest concern and identify it as a
leading cause of insufficient sleep.
Fear of pain also has an effect on patients,
especially with patients facing major surgery or
a serious illness. Pancreatica, for example, says
that fear of pain is the primary concern of most
patients who have advanced pancreatic cancer.
The memory of pain is a long-lasting side effect
for many patients, especially those who were
critically ill. Recent studies of ICU patients showed
that 82 percent remembered pain or discomfort
10
associated with the endotraceal tube and 77 percent
said they remembered experiencing pain during
their ICU stay. One week after discharge from the
Intensive Care Unit after cardiac surgery, 82 percent
of patients said that pain was the most common
traumatic memory of that hospital experience. Six
months later, 38 percent still stated that pain was
their most traumatic memory from their ICU stay.
Researchers in another study discovered that
17 percent of ICU patients remembered pain six
months later and that 18 percent were at high
risk for developing post traumatic stress disorder
(PTSD) as the result. In a long-term follow-up
questionnaire study of med/surg patients treated
in ICU for acute respiratory distress syndrome,
those who recalled pain while in the ICU had a
38 percent higher incidence of chronic pain, a 27
percent higher occurrence of PTSD symptoms,
and a 21 percent lower health-related quality of
life as compared with control subjects.
The stress response associated with pain can
have deleterious consequences for critically ill
patients and can complicate treatment plans. Pain
and stress can increase circulating catecholamine
to cause arteriolar vasoconstriction, reduce tissueoxygen partial pressure and impair tissue perfusion.
Pain can trigger other responses, such as catabolic
hypermetabolism that can result in hyperglycemia,
lipolysis, and muscle breakdown to provide muscle
substrate. Hypoxemia and catabolic stimulation
associated with pain impair wound healing while
increasing the risk for wound infection. Pain also
suppresses activity of natural killer cells, decrease
the number of cytotoxic T cells, and reduce
neutrophile phagocytic activity.
While pain can cause these measurable
responses, pain cannot be evaluated with laboratory
testing – patients rely on a practitioner’s ability to
conduct a reliable assessment through interview
and observation. Healthcare professionals must
frequently assess and reassess patients for pain then
titrate interventions to reduce the risk for negative
effects associated with inadequate or excessive
analgesic therapy. In order to do this, clinicians and
nurses should perform routine and reproducible
pain assessments for all patients suffering from
acute or chronic pain. Healthcare providers can
use patient self-report or systematically applied
behavioral measures to identify and assess pain,
then providing treatment for that pain early, before
the pain becomes severe.
Assessment of Pain
Pain assessment is the cornerstone of clinical
pain management. While pain is a subjective
experience, pain assessment and management
requires objective standards of care.
Several studies show that certain segments
of the population are at greater risk for undermedication and poor assessment. Patients at
highest risk include:
Minorities
Adults older than 70 years
Children
Women
Individuals with a history of substance abuse
Patients who are especially anxious about
postoperative problems
Individuals who have high expectations for
optimal pain management
Patients with a history of chronic pain and
preoperative pain
Those who seem to “look healthier”
Patients who experience breakthrough pain
Patients with neuropathic pain or bone
metastases
To detect pain reliably, clinicians depend
on assessment tools adaptable to situations
where patients have diminished communication
capabilities. A practitioner can even use behavioral
reactions to measure pain, as long as the patient’s
motor skills is intact.
Many clinicians rely on the WILDA approach
to pain assessment: Words, Intensity, Location,
Duration, and Aggravating/Alleviating Factors.
This approach prompts clinicians to ask patients
to describe their pain using words that guide the
practitioner towards the appropriate intervention
for that type of pain. Patients may use the words
burning, shooting, or tingling sensation to describe
neuropathic pain, for example, which does not
respond as well to opioids alone as it does to
diazepine.
A patient’s self-report will always be the gold
standard for identifying and quantifying pain, so
clinicians should always start by asking patients
to rate their pain. One study shows the “0 to 10”
numeric rating scale is the most valid and feasible
of the five pain-intensity rating scales investigated.
Patients in many settings cannot self-report,
leaving it up to clinicians to employ structured,
reliable, valid, and feasible tools when assessing
patient pain. Healthcare professionals must assess
pain routinely and repetitively. There are currently
no objective pain monitors but there are valid and
reliable bedside pain assessment tools that rely
primary on patient behaviors as indicators.
After assessment, the clinician may recommend
one or more pain management approaches,
including
pharmacotherapy,
interventional
procedures, physical therapy, rehabilitation, and
complementary therapies.
Pain Management
Approaches
Medication, specifically opioid therapy, is the
primary approach to managing acute pain, especially
in critically ill patients. Fentanyl, hydromorphone,
methadone, morphine, and remifentanil are usually
the medications of choice for management of
acute pain.The optimal choice of opioid and dosing
regimens relies largely on the pharmacokinetic and
pharmacodynamic properties of the drug, and the
setting in which it is given.
Dosing methods are another consideration.
The decision between intermittent and
continuous IV strategies may be contingent on
drug pharmacokinetics, frequency and severity
of pain, and the patient’s mental status. Clinicians
must restrict enteral administration of analgesics
to only patients with adequate gastrointestinal
absorptive capacity and motility. Practitioners may
opt for regional or neuraxial modalities for use as
postoperative analgesia following selected surgical
procedures.
Other analgesics and pain-modulating
medications, including local and regional anesthetics
such as bupivacaine, NSAIDs such as ketorolac and
ibuprofen, IV acetaminophen and anticonvulsants
are effective as adjunctive pain medications that
can reduce opioid requirements.
IV acetaminophen has recently gained approval
for use in the United States. One study showed
that, when used in conjunction with opioids for
postoperative pain, intravenous paracetamol
reduced the use of opioids, extubation time, and
adverse effects associated with opioids.
Unfortunately, researchers have not yet
adequately assessed the safety profile and
effectiveness as the sole agents of analgesia for use
in critically ill patients. Furthermore, it is unclear
whether the benefits of these non-opioid pain
management techniques commonly used outside
the ICU will carry over to patients in the Intensive
Care Unit.
Researchers continue to investigate other
non-opioid pain relievers. One study found, for
example, that cabapentin and carbamazepine can
be effective for treating neuropathic pain.
Non-pharmacologic and complementary
interventions, such as relaxation techniques or
music therapy, can reduce the need for opioids or
enhance the analgesic effects of pain medications.
More research is necessary to investigate the
effectiveness of these non-pharmacologic
interventions in critically ill patients.
Taking the Pulse of Healthcare
Technology Investments
By Ahmed Fahmy, Director, Innovation Development, Zebra Technologies
P
atients expect high-quality healthcare,
whether they are in the hospital or at a
medical office. They want reassurance
that the staff will know them, their medical
history, results of their recent tests and most
impor tantly, that they will be taken care of
in a timely manner, no matter what health
issue brought them in. With healthcare costs
skyrocketing, this has become more of a
demand than an expectation.
To complicate matters, past research
indicates that nurses spend more than
55% of their time in documentation and
care coordination. A nursing shortage is
also predicted, according to the American
Nurses Association. Consider that over the
past decade, the average age of employed
registered nurses (RNs) has increased by
nearly two years, from 42.7 years in 2000 to
44.6 years in 2010, with 55% of the nursing
population above 50 years old. Lastly,
hospitals face a grim reality that thousands
of patients die each year from healthcareassociated infections and, most regrettably,
human medical error.
These challenges are operational in
nature. Mitigating them, as well as meeting
or exceeding patient expectations, takes
technology. Smar t devices – connected to
a reliable wireless network with bandwidth
to spare – can deliver access to timely,
accurate and actionable patient data. Armed
with the ability to input and access real-time
patient data anywhere, healthcare workers
can quickly identify a life-threatening
drug allergy or quickly identify surgical
procedure complications. Administrators
can also determine the location of their staff
members, what activities they are performing
and how well they are performing them. The
ability to integrate patient medical records
and needed care data with location and
availability information on specific medical
supplies, equipment, and clinical staff makes
it easier to respond quickly to patient
needs. The quality of the patient care given
along with a healthcare facility’s reputation
and bottom line, will depend on those
technology investments.
Better Visibility
Improves Outcomes
Visibility into the facility is everything –
including supplies, equipment, staff and
patient health details. It allows healthcare
organizations to achieve key patient care
outcomes, satisfaction and operational goals.
The benefits of enabling nurses’ mobility and
other healthcare professionals with por table
devices and solutions that can scan patient
wristbands and connect to critical patient
information via wireless access points are
vast and hard to ignore. These devices can
also streamline administrative processes and
workflows so that nurses can spend more
time responding to patients’ needs, and less
time looking for equipment, medications and
updating paper char ts. Integrated mobile
solutions can bring complete patient data
directly to the bedside, where decisions and
updates can be made immediately. They also
enhance and facilitate greater collaboration
between doctors and other healthcare
practitioners.
What does a “connected” healthcare
model look like? Imagine if patient data,
hospital staff and equipment are all connected
in real-time. Imagine if the patient experience
can be tracked from the time the patient
is admitted to the hospital to the time the
patient is discharged. Waiting time is limited,
the patient is aware of exactly when a doctor
or nurse will arrive, when a procedure will
star t and when final test results will be
ready. The hospital would also have real-time
visibility into the equipment and staff that a
patient’s procedure requires - and the digital
intelligence to know where those assets
and staff members are located, to facilitate
the procedure efficiently. When the patient
is discharged from the healthcare facility,
he or she does so with real-time access
to test results, his/her doctor’s orders and
educational material that enables a positive
healthcare outcome. Family and caregivers
can even monitor their loved one’s progress
inside the hospital and out.
Also consider health outbreaks in this
scenario - hospital operations can determine
in a matter of minutes the source of the
outbreak and who was exposed from staff,
to equipment and people. The outbreak
can then be contained and other patients
protected from being infected, potentially
saving lives and significant cost implication to
the healthcare facility.
Reaping Connected
Benefits
Better quality patient care translates into
more positive healthcare outcomes via more
efficient and streamlined visibility into resources
and operations. With thoughtful investment
in integrated technology and an optimized
management platform, the critical, life-saving
goals of healthcare organizations are now within
reach. Higher quality, better outcome and more
cost-effective models of patient care are now
possible – and deliver big benefits – with an
ideal mix of technology along with a focus on
the healthcare workers’ workflows and patients.
At some point, we will all be patients.
What level of patient care and quality of
experience will you expect?
#arabhealth
@arab_health
11
NMC acquires ProVita
International Medical Center
A
priority sector for the government,
healthcare has come a long way over the
past few years. The Abu Dhabi healthcare
market saw a steep growth in patient volumes
in the immediate wake of Mandatory Health
Insurance Implementation in the emirate. This
was a phase of capacity building in the industry.
However, to continue this growth, there is now a
need to focus on capability building. Organisations
should carefully analyse the requirements of the
population, understand the prevalent gaps across
the continuum of healthcare delivery spectrum,
and build business models to fill these gaps.
Access to healthcare services beyond the
traditional hospital setting provides an interesting
opportunity to take healthcare in the UAE to the
next level. Keeping this in mind, NMC completed
the acquisition of ProVita, the category creator for
long term care in the UAE.
“NMC Health’s acquisition of ProVita
International Medical Center was a positive
strategic move in further enhancing NMC’s broad
coverage of the UAE and GCC continuum of care.
For ProVita, being a part of a large provider with
such such deep roots here in the Middle East and
with such a strong commitment to quality care was
a natural fit”, noted Michael Davis, CEO of ProVita.
ProVita International Medical Center is the
foremost provider of acute, ventilated care in the
region. ProVita provides optimum care to individuals
who are ventilator dependent in a home-like setting.
The goal is to promote and enhance the quality
of life of each of our residents. Their facilities in
Abu Dhabi and Al Ain provide exceptional care
and rehabilitative services to individuals who have
previously been treated in ICU or have had to go
abroad to get the quality of care they required.
12
ProVita employs a multidisciplinary staff of
Nurses, Physicians, Occupational, Respiratory and
Physiotherapists, Dietitians, and Speech and Language
Pathologists. Located in Abu Dhabi and Al Ain, they
care for adult and pediatric patients with a multitude
of underlying conditions including congenital
neuromuscular disorders, muscular dystrophy, ALS,
and other neurological impairments, many as a result
of road traffic accidents, heart attacks, and strokes
or other injuries or illnesses. ProVita is surveyed and
accredited by the Joint Commission International and
is recognised as a ‘Gold Seal Hospital”.
ProVita holds affiliation agreements with the
Spaulding Rehabilitation Network and the Joslin
Diabetes Center in Boston, Massachusetts. Both
hospitals serve as teaching institutions for the worldrenowned Harvard Medical School. Spaulding and
Joslin provide education and training, consultation,
and quality and operational assessments for
ProVita’s multi-disciplinary clinical team. The
clinicians apply western standards of care, but with a
local, cultural approach to each resident’s everyday
life. Recognising the importance of family in the UAE,
ventilator-dependent residents are often allowed
visits to home, the mosque, events such as weddings
and birthday parties, sporting events, movies and
other social outings as their clinical condition allows.
Several residents attend school or university daily.
And each resident is always accompanied by at least
two trained clinical staff members on every outing.
ProVita International Medical Center believes in
the human potential of each resident, regardless of
their neurological or clinical condition and strive to
provide each resident with the highest quality of life
possible.
Take the case of Yusra Alhattai, who came to
ProVita having spent most of her life in an ICU with
limited access to the outside world. Living at ProVita
has given Yusra access to the type of healthcare she
requires, but allows her to live her life in a homelike
environment with nursing, respiratory therapy, and
physician oversight around the clock.
It had long been Yusra’s ambition to study art and
ProVita arranged for a teacher to visit her weekly. It was
then that Yusra realised what she hoped would be an
enjoyable passtime, would actually reveal an incredibel
talent for creating exceptional pieces of contemporary
art. Yusra’s talent was recognised by her hero Shaikh
Saif bin Zayed Al Nahyan who asked to exhibit her
work at the 2013 Access Abu Dhabi event. And Yusra
now plans to open an art studio, an ambition that this
inspirational yong woman will undoubtedly achieve
with her unique talent and immense dedication.
The addition of the 26-bed unit, as well as the
opening of the new NMC Royal Hospital in Khalifa
City A, will broaden the types of patients they care
for and will allow them to promote and enhance
the quality of life of long-term care patients whose
conditions do not allow them to be too far from an
acute care hospital. They hope to leave an impact
on many more Yusra’s in times to come.
Aster@Home Programme Launched
A
ster Hospital and Clinics announced that
it is taking personalised healthcare to the
next level and launched the Aster@Home
programme at the show.The programme is designed
to help the local community address their medical
needs from the comfort of their own homes.
Aster@Home aims to deliver care to patients
not just from the hospital and clinics but also at
home through innovative and specialised new
platforms. It will enable patients to get basic
healthcare services at home for initiatives relating
to pharmacy deliveries, doctor’s visits, nursing
services and more.
Dr. Azad Moopen, Chairman and Managing
Director of Aster DM Healthcare said, “We are
continuously searching for ways that we can
use both new technology and opportunities in
medicine to help set a standard that contributes
towards the UAE Vision 2021 national agenda in
providing a world-class healthcare system.Through
the Aster@Home programme, we are further able
to address the medical needs of our patients both
before and after their clinic and hospital visits. By
enabling a smooth, easy-to-use mobile service we
hope we are seeking to improve the health of the
nation even further.”
One of the highlights of Aster@Home is
its home monitoring system for diabetic and
hypertensive patients under its “Aster Chronic
Disease Care” programme. With diabetes affecting
over one million people or 19% of population in
the UAE alone (International Diabetes Federation’s
Diabetes Atlas 2015) and cardiovascular diseases
on the rise, Aster will support the challenges
presented by those facing the lifestyle-related
disease and in particular aid those who require
extra care due to elevated levels of glucose
or suffer from hypertension. In its initial phase,
patients will be given free gadgets to help monitor
their sugar levels or blood pressure at home. This
programme has shown successful results during its
pilot phase.
The diabetes and blood pressure home
monitoring devices are provided for free to Aster
clinic patients who can choose to subscribe to the
home monitoring programme, following doctor’s
advice. Daily readings will be captured and instantly
recorded or sent via USB cable or Bluetooth
to a smart phone, shared through Android or
iPhone application and also can be easily made
accessible to the doctor via cloud technology. If
any concerning reading is captured the patient will
automatically receive an SMS and phone call from
the clinic. If necessary, the patient will also be asked
to visit the clinic immediately, without the need for
prior booking, to be treated by the doctor.
delivery of the required medications.
Aster Grace is another novel initiative under
Aster@Home wherein families of patients can
book a nurse or physiotherapist to provide care.
The service, initially available in Abu Dhabi, helps
both patients and their families to have expert
medical assistance at home for continued care.
It also takes out the worry for family members
who cannot stay home during the day to look after
unhealthy loved ones.
Aster@Home are also planning to launch a series
of new initiatives including home sample collection
services for laboratory tests, post-natal care for
mothers who need extra hands to attend to their
babies, post-operative care for patients to avoid
revisits to the hospital and physiotherapy at home.
Aster@Home currently includes services such
as the Doctor-On-Call 800-ASTER, free home
delivery of medicines by Aster Pharmacy, nursing
and physiotherapy home care services by Aster
Grace Nursing & Physiotherapy in Abu Dhabi.
The doctors are able to provide nonemergency care for ailments such as fever, upper
respiratory tract infections, cough and colds, flu
and pneumonia, vomiting and diarrhoea, allergic
reactions, dizziness, gastrointestinal and urinary
tract infections, among others.
For patients who run out of medications and
have no immediate capability to go to the nearest
pharmacy, Aster Pharmacy is able to deliver right
at their doorsteps for their convenience. By
calling 800-ASTER, the pharmacy will provide free
SEE AND TREAT
Innovations in Surgical Applications
Visit us on stand 3E30 at Arab Health 2016.
Follow us on Twitter @OlympusMedUIMEA
www.olympus.co.uk/medical
#arabhealth
@arab_health
13
Roche Diagnostics Middle East
sets standards for innovation,
automation and patient care
M
edical care has been undergoing
tremendous advances in the Middle East.
Roche Diagnostics Middle East (RDME)
is a pioneer in leading this development in invitro diagnostics, by supporting laboratories to
achieve a higher level of performance, efficiency
and sustainability. It has supported a large number
of leading and prominent healthcare institutions to
move from multiple analyzers and workflows to
comprehensive, integrated laboratory solutions;
meeting international standards and certifications.
Roche Diagnostics is also leading the industry in
addressing unmet medical needs with new and
medically enhanced diagnostic tests, supporting
doctors and patients with a better information
basis for medical decisions and treatment solutions.
For the first time in the Middle East, Roche
showcased the cobas c 513 analyzer; a dedicated
analyzer for glycosylated hemoglobin (HbA1c)
testing designed to deliver the accuracy, precision,
automated analyses and simplicity that allows
laboratories to achieve the medical value and
workflow efficiency they need the most by
delivering 400 HbA1c results per hour. The
direct results negate the need to perform time
consuming, manual result interpretations; thereby,
saving valuable time and laboratory resources. The
cobas c 513 analyzer runs on the established TinaQuant HbA1c A1cDx generation 3 test; also used
across the Roche laboratory hbA1c portfolio to
ensure the delivery of high quality and accurate
results.
Also unveiled at the Roche Diagnostics booth is
the new cobas e 801 module; the successor of the
successful cobas e 601/e 602 with innovations that
doubles capacity and speed in the same footprint.
The cobas e 801 module can be integrated to the
cobas 8000 to form high volume testing platforms.
Other innovative features in the solution include:
automated, multi-vendor cap-piercing, maximized
reagent utilization and integrated barcode scanning
for samples and reagents.
Full range of pioneering
pressure mattresses on display
U
K pressure ulcer specialist Rober,
are showcasing their full range
of alternating mattress solutions
which cater for a variety of patients’ needs
from everyday nursing environments to
acute care facilities, at Arab Health 2016.
The pioneering range of mattresses
and overlays – which includes solutions
for immobile, critically ill and bariatric
patients - have been developed in
conjunction with clinicians and feature
clinically proven technology that prevents
pressure injuries from developing. They also
promote the healing of established ulcers.
The new generation of mattresses are
fully automatic and patients nursed upon
them require less manual repositioning.
The company has focused on four key
areas - microclimate control, patient safety
and comfort, maximising infection control
and offering additional nursing support.
Two different mattress ranges are available
from Rober, the premium NoDec® range and
AirFlex®, a secondary ‘cost effective’ range
of mattress solutions designed to fulfil the
requirements of ‘affordable healthcare. Both
ranges will be on show at Arab Health 2016.
Mike Hutson, Chief Executive of Rober, said:
“Over the last few years we have invested
heavily in R&D to create a full range of
pressure ulcer solutions that cater for all
types of patients, in different healthcare
settings. I am delighted to now have the
range complete and for it to be on show at
Arab Health.”
Rober are located on stand Z1D10.
Testing of dialysis water
in UAE increasing in line with growing incidence of kidney diseases and diabetes
T
he number of dialysis water testing in
the UAE has been increasing over the
years, a trend that is attributed to the
growth in the number of kidney disease and
diabetes patients.
Prime Certification and Inspection, a sister
company of Geoscience Testing Laboratory
and the region’s leading quality and compliance
solutions provider, reports that the use of
their dialysis water testing services by various
healthcare centres in the UAE increased by 15
per cent in 2015 over 2014.
Industry estimates show that over 2,000
chronic kidney disease patients are undergoing
dialysis in the country and this number increases
by 10 to 15% each year. In the UAE, the rising
incidence of kidney failure is primarily linked to
the prevalence of diabetes.
Engineer Mary Jane Alvero-Al Mahdi, CEO
of Prime Certification and Inspection, said: “We
have seen a 15 per cent growth in our dialysis
water testing services over the last year both
from major government and privately-owned
hospitals. This increase can be attributed to
the increasing number of kidney disease and
diabetic patients in the country.
“Treating dialysis patients requires extreme
volumes of water. While a healthy individual
would only require a daily water intake of
2 litres or 14 liters per week, a single dialysis
treatment for 4 hours, three times a week, will
expose the patient to more than 500 litres of
water per week. And because dialysis patients
14
are vulnerable to contaminants in the water
used to prepare concentrate and dialysis fluid,
the UAE requires that dialysis water is tested up
to the highest levels to ensure safety.”
With more than 400 qualified staff spread
across multiple facilities, the company has one
of the largest pools of experts and professionals
in the field of testing, inspection, certification,
training, and consultancy.
The International Diabetes Federation
(IDF) 2014 data estimates that there were
803,900 cases of diabetes in UAE. The country
ranks 16th globally and fifth regionally in the
occurrence of diabetes, and one in five of
the population suffers from the condition.
Sedentary lifestyle, unhealthy diet as well as
low awareness about the disease and the risks
involved are considered to be the major factors
influencing this healthcare trend.
Diabetes can damage the kidney’s filtering
function when high levels of blood sugar strain
the kidney to filter too much blood.The kidney’s
blood vessels, which have filters to supposedly
remove waste products from the blood but
retain useful substances, are injured. Waste
products build up in the blood while protein
is excreted in the urine. The body also retains
more water and salt than it should, causing
weight gain and ankle swelling. In time, the
organ loses its function leading to kidney failure.
The prevalence of other lifestyle diseases
in the UAE such as obesity and high blood
pressure further contributes to the increasing
incidence of end stage renal disease among
residents. Such patients require continuous
dialysis, the treatment that substitutes for lost
function of the kidney.
More dialysis centres have opened in the UAE
to cope up with the demand. A number of these
dialysis centres have adopted internationallyaccredited protocols and standards in providing
high-quality dialysis treatment and clinical care
to patients. This is in line with the UAE Vision
2021 National Agenda that aims to achieve a
world-class healthcare system.
“In ensuring that highest healthcare
standards are employed, various government
and private hospitals have been partnering
with Prime to implement dialysis water
testing including microbiological, chemical and
endotoxin analyses. A lot of hospitals in the
UAE have realised that this testing is essential
especially that their patients are exposed
to large amount of dialysis water during
treatments,” Al Mahdi said.
“Dialysis patients lack adequate barriers to
contaminants that are waterborne and their
bodies are unable to get rid of any contamination
that exists in the water. Dialysis water testing
enables hospitals to safeguard their patients
against life-threatening issues and to prevent
adverse patient outcomes from dialysis because
of contaminated water,” she added.
“To help the healthcare centres maintain
routine testing of dialysis water, we have kept
the turn-around time to a minimum with the
cultural method in microbiological analysis
taking approximately 5 to 7 days to complete
all reporting procedures,” explained Al Mahdi.
Exhibitor
“We are here because the region is very
important to us but also because this is a
very important international event. We get
to see and speak to customers from such a
wide variety of countries and nationalities,
and have received extremely good
feedback from customers with very high
customer engagement. This is our 4th year
at Arab Health and we are very satisfied”
Marcus Ostlander, Business Leader,
Honeywell from Germany.
Exhibitor
“This is our first ever time at Arab
Health and it has been an excellent
start. Of course we were apprehensive,
especially as a construction company
rather than a medical devices
organization, but after the first two days
we expect to easily cover our costs of
exhibiting and will definitely plan on
returning next year”. Andy Newbould,
Sales Director, Bioclad from UK
Delegates
“Arab Health is good conference. Arab
Health congress is an ideal platform
to learn about new topics, this Arab
Health introduced me to a new
topic, that I look forward to discuss
in Saudi Arabia, I will talk about data
governance and AH opened my mind
to this topic”– Dr Hany Gaballa,
Operation Manager, Selat , KSA
Visitor
“We are medical dealers and this is
the biggest exhibition in this region
so we’ve been coming here eight
years in a row, it’s become a tradition
and we wouldn’t miss it! We always
see something new, meet new
organizations, potential customers,
partners and so on. It’s the place to
be” – Mohamad Issa, from Lebanon.
#arabhealth
@arab_health
15
Root Patient Monitoring
and Connectivity Platform
®
Please visit us at
Arab Health 2016
Saeed Hall
Stand S1 B30
Root is an intuitive patient monitoring and connectivity platform designed to transform
patient care. Root is now available with noninvasive blood pressure and temperature, in
addition to a combination of the following high-impact innovations:
> Masimo’s breakthrough measurements from the Radical-7® handheld or Radius-7™
patient-worn monitor
> Flexible measurement expansion through Masimo Open Connect™ (MOC-9™)—with
SedLine brain function monitoring, ISA™ capnography and gas monitoring, O3™
regional oximetry, and the ability to expand with additional third-party measurements
®
> Built-in Iris™ connectivity for standalone devices such as IV pumps, ventilators,
hospital beds, and other patient monitors
> Automatic display of parameters, waveforms, and viewing configurations, based
on each clinician’s presence tag with MyView™
www.masimo.co.uk
For professional use. See instructions for use for full prescribing information,
including indications, contraindications, warnings, and precautions.
www.masimo.co.uk | +41 32 720 1188

hrh PrinCess haYa to hiGhliGht develoPMents in

Transcription

Similar documents

chimb.ca

FestusManor Good News Gazette Update

Lanvera Borland-Groover Clinic Case Study

healthcare leaders

InBody720 Spec Sheet

Sports/Activity Physical Form

Zanubia Shams - Zulekha Hospitals

Profile New_Dr Zulekha D

Center for Domestic Preparedness

smart healthcare consumer